← FDA Drug Approvals (Drugs@FDA)
IMBRUVICA
NDA · New Drug Application · Sponsor: PHARMACYCLICS LLC · Approved 2018-02-16
Drug application
- FDA Application #
NDA210563- Application type
- New Drug Application
- Brand name
- IMBRUVICA
- Generic name
- IBRUTINIB
- Active ingredients
- IBRUTINIB
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- PHARMACYCLICS LLC
- Manufacturer
- Pharmacyclics LLC
- First approval
- 2018-02-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown